KOPRANPharmaceuticals

Kopran LtdProfit & Loss Statement

113.43
-6.75%

Kopran Ltd Profit & Loss Statement (Annual)

Metric20252024202320222021
EBITDA76.88 Cr89.02 Cr53.28 Cr96.51 Cr
EBIT61.29 Cr76.14 Cr40.57 Cr85.41 Cr
Net Interest Income-9.34 Cr-8.59 Cr-4.38 Cr-3.79 Cr
Interest Expense9.34 Cr8.59 Cr4.50 Cr3.63 Cr
Normalized Income38.55 Cr50.96 Cr27.24 Cr60.91 Cr
Net Income From Continuing And Discontinued Operation38.55 Cr50.96 Cr27.23 Cr61.03 Cr
Total Expenses572.30 Cr553.07 Cr502.89 Cr397.52 Cr
Diluted Average Shares4.83 Cr4.83 Cr4.82 Cr4.43 Cr
Basic Average Shares4.83 Cr4.82 Cr4.82 Cr4.43 Cr
Diluted EPS7.9910.555.6513.77
Basic EPS7.9910.575.6513.77
Diluted NI Availto Com Stockholders38.55 Cr50.96 Cr27.23 Cr61.03 Cr
Net Income Common Stockholders38.55 Cr50.96 Cr27.23 Cr61.03 Cr
Otherunder Preferred Stock Dividend0.000.000.000.00
Net Income38.55 Cr50.96 Cr27.23 Cr61.03 Cr
Minority Interests0.000.000.000.00
Net Income Including Noncontrolling Interests38.55 Cr50.96 Cr27.23 Cr61.03 Cr
Net Income Continuous Operations38.55 Cr50.96 Cr27.23 Cr61.03 Cr
Tax Provision13.40 Cr16.59 Cr8.83 Cr20.75 Cr
Pretax Income51.95 Cr67.54 Cr36.07 Cr81.78 Cr
Other Non Operating Income Expenses1.69 Cr7.44 Cr0.62 Cr1.18 Cr
Special Income Charges0.000.00-28000.000.16 Cr
Net Non Operating Interest Income Expense-9.34 Cr-8.59 Cr-4.38 Cr-3.79 Cr
Interest Expense Non Operating9.34 Cr8.59 Cr4.50 Cr3.63 Cr
Operating Income57.31 Cr61.53 Cr45.29 Cr76.76 Cr
Operating Expense167.68 Cr151.13 Cr128.89 Cr113.41 Cr
Other Operating Expenses91.55 Cr85.95 Cr46.38 Cr41.28 Cr
Depreciation And Amortization In Income Statement15.59 Cr12.89 Cr12.71 Cr11.10 Cr
Depreciation Income Statement15.59 Cr12.89 Cr12.71 Cr11.10 Cr
Gross Profit224.99 Cr212.65 Cr174.18 Cr190.17 Cr
Cost Of Revenue404.62 Cr401.94 Cr374.00 Cr284.11 Cr
Total Revenue629.60 Cr614.59 Cr548.18 Cr474.28 Cr
Operating Revenue629.60 Cr614.59 Cr548.18 Cr474.28 Cr
Tax Effect Of Unusual Items0.000.00-6857.480.04 Cr
Tax Rate For Calcs0.260.250.240.25
Normalized EBITDA76.88 Cr89.02 Cr53.29 Cr96.35 Cr
Total Unusual Items0.000.00-28000.000.16 Cr
Total Unusual Items Excluding Goodwill0.000.00-28000.000.16 Cr
Net Income From Continuing Operation Net Minority Interest38.55 Cr50.96 Cr27.23 Cr61.03 Cr
Reconciled Depreciation15.59 Cr12.89 Cr12.71 Cr11.10 Cr
Reconciled Cost Of Revenue404.62 Cr401.94 Cr374.00 Cr284.11 Cr
Interest Income0.30 Cr1.70 Cr1.32 Cr0.29 Cr
Rent Expense Supplemental1.97 Cr1.95 Cr1.62 Cr2.58 Cr
Other Special Charges-12000.0028000.000.47 Cr0.88 Cr
Write Off-6.46 Cr0.00-0.62 Cr0.14 Cr
Total Other Finance Cost2.21 Cr1.58 Cr1.49 Cr1.72 Cr
Interest Income Non Operating0.30 Cr1.70 Cr1.32 Cr0.29 Cr
Selling General And Administration19.86 Cr18.45 Cr17.09 Cr26.78 Cr
Selling And Marketing Expense9.40 Cr9.31 Cr8.54 Cr18.22 Cr
General And Administrative Expense10.46 Cr9.15 Cr8.55 Cr8.56 Cr
Rent And Landing Fees1.97 Cr1.95 Cr1.62 Cr2.58 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.